Marie-Emilie Francart
University of Liège
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marie-Emilie Francart.
Cancer Research | 2016
Morgane Bourcy; Meggy Suarez-Carmona; Justine Lambert; Marie-Emilie Francart; Hélène Schroeder; Céline Delierneux; Nicolas Skrypek; Erik W. Thompson; Guy Jerusalem; Geert Berx; Marc Thiry; Silvia Blacher; Brett G. Hollier; Agnès Noël; Cécile Oury; Myriam Polette; Christine Gilles
Epithelial-mesenchymal transition (EMT) is prominent in circulating tumor cells (CTC), but how it influences metastatic spread in this setting is obscure. Insofar as blood provides a specific microenvironment for tumor cells, we explored a potential link between EMT and coagulation that may provide EMT-positive CTCs with enhanced colonizing properties. Here we report that EMT induces tissue factor (TF), a major cell-associated initiator of coagulation and related procoagulant properties in the blood. TF blockade by antibody or shRNA diminished the procoagulant activity of EMT-positive cells, confirming a functional role for TF in these processes. Silencing the EMT transcription factor ZEB1 inhibited both EMT-associated TF expression and coagulant activity, further strengthening the link between EMT and coagulation. Accordingly, EMT-positive cells exhibited a higher persistance/survival in the lungs of mice colonized after intravenous injection, a feature diminished by TF or ZEB1 silencing. In tumor cells with limited metastatic capability, enforcing expression of the EMT transcription factor Snail increased TF, coagulant properties, and early metastasis. Clinically, we identified a subpopulation of CTC expressing vimentin and TF in the blood of metastatic breast cancer patients consistent with our observations. Overall, our findings define a novel EMT-TF regulatory axis that triggers local activation of coagulation pathways to support metastatic colonization of EMT-positive CTCs. Cancer Res; 76(14); 4270-82. ©2016 AACR.
Histochemistry and Cell Biology | 2012
Nicolas Johnen; Marie-Emilie Francart; Nicolas Thelen; Marie Cloes; Marc Thiry
The epithelial–mesenchymal transition (EMT) plays a crucial role in the differentiation of many tissues and organs. So far, an EMT was not detected in the development of the auditory organ. To determine whether an EMT may play a role in the morphogenesis of the auditory organ, we studied the spatial localization of several EMT markers, the cell–cell adhesion molecules and intermediate filament cytoskeletal proteins, in epithelium of the dorsal cochlea during development of the rat Corti organ from E18 (18th embryonic day) until P25 (25th postnatal day). We examined by confocal microscopy immunolabelings on cryosections of whole cochleae with antibodies anti-cytokeratins as well as with antibodies anti-vimentin, anti-E-cadherin and anti-β-catenin. Our results showed a partial loss of E-cadherin and β-catenin and a temporary appearance of vimentin in pillar cells and Deiters between P8 and P10. These observations suggest that a partial EMT might be involved in the remodelling of the Corti organ during the postnatal stages of development in rat.
Developmental Dynamics | 2018
Marie-Emilie Francart; Justine Lambert; Aline M. Vanwynsberghe; Erik W. Thompson; Morgane Bourcy; Myriam Polette; Christine Gilles
Epithelial–mesenchymal transitions (EMTs) associated with metastatic progression may contribute to the generation of hybrid phenotypes capable of plasticity. This cellular plasticity would provide tumor cells with an increased potential to adapt to the different microenvironments encountered during metastatic spread. Understanding how EMT may functionally equip circulating tumor cells (CTCs) with an enhanced competence to survive in the bloodstream and niche in the colonized organs has thus become a major cancer research axis. We summarize here clinical data with CTC endpoints involving EMT. We then review the work functionally linking EMT programs to CTC biology and deciphering molecular EMT‐driven mechanisms supporting their metastatic competence. Developmental Dynamics 247:432–450, 2018.
School of Biomedical Sciences; Faculty of Health; Institute of Health and Biomedical Innovation | 2017
Marie-Emilie Francart; Justine Lambert; Aline M. Vanwynsberghe; Erik W. Thompson; Morgane Bourcy; Myriam Polette; Christine Gilles
Archive | 2017
Justine Lambert; Morgane Bourcy; Marie-Emilie Francart; Agnès Noël; Myriam Polette; Christine Gilles
Archive | 2016
Justine Renauld; Marie-Emilie Francart; Nicolas Thelen; Nicolas Johnen; Marie Cloes; Marc Thiry
Archive | 2016
Justine Lambert; Morgane Bourcy; Marie-Emilie Francart; Agnès Noël; M Polette; Christine Gilles
Faculty of Health; Institute of Health and Biomedical Innovation | 2016
Morgane Bourcy; Meggy Suarez-Carmona; Justine Lambert; Marie-Emilie Francart; Hélène Schroeder; Céline Delierneux; Nicolas Skrypek; Erik W. Thompson; Guy Jerusalem; Geert Berx; Marc Thiry; Silvia Blacher; Brett G. Hollier; Agnès Noël; Cécile Oury; Myriam Polette; Christine Gilles
Archive | 2015
Justine Lambert; Morgane Bourcy; Marie-Emilie Francart; Christine Gilles
Archive | 2015
Marie-Emilie Francart; Morgane Bourcy; Justine Lambert; Meggy Suarez-Carmona; Guy Jerusalem; Cécile Oury; Agnès Noël; Christine Gilles